February 2017 FDA Recall Drug by Hospira Inc., A Pfizer Company
D-0480-2017 - Lack of Sterility Assurance

This Class II drug recall was voluntarily initiated by Hospira Inc., A Pfizer Company on February 10, 2017 for the product Drug. The FDA reported the reason for recall as lack of sterility assurance. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0480-2017

Reason for Recall
Lack of Sterility Assurance: customer report of leaking bag
Initiated
02-10-2017
Reported
03-01-2017
Quantity
578,784 bags

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Hospira Inc., A Pfizer Company
Nationwide and Puerto Rico
METRONIDazole Injection, USP 500 mg (5 mg/mL) in 100 mL Single Dose Flexible Container, Rx only, For IV Use, Hospira Inc., Lake Forest, IL --- NDC 0409-7811-24

Batch or Lot Expiration Information

Lot# Lot: 54-054-JT, 6/1/2017